Last reviewed: May 12, 2026
Last updated: May 12, 2026
Written by:
Jay Hastings
,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — your resource for evidence-based guidance on blood testing & biomarkers. Browse all Blood Testing & Biomarkers education
Interleukin-10 (IL-10) is one of the body's master anti-inflammatory signals. When IL-10 levels run low, the immune system loses part of its brake pedal — and that imbalance has been connected to a wide range of chronic conditions. Genetics helps explain why some people produce less IL-10 than others, with variants in the IL10 gene itself sitting at the center of the story.
What IL-10 does in the body
IL-10 is a cytokine — a small signaling protein released mainly by immune cells such as regulatory T cells and macrophages. Its job is to dial inflammation back down once a threat has passed, limiting collateral damage to healthy tissue. Think of it as the counterweight to pro-inflammatory signals like TNF-alpha and IL-6. When IL-10 is abundant and working well, inflammation resolves cleanly. When it is scarce, inflammatory responses can run longer and hotter than they should.
Which conditions are linked to low IL-10
Research has associated reduced IL-10 activity with several inflammatory and autoimmune conditions, including inflammatory bowel disease, rheumatoid arthritis, and psoriasis. Low IL-10 signaling has also been studied in the context of cardiovascular disease, where unchecked vascular inflammation contributes to plaque, and in metabolic conditions tied to chronic low-grade inflammation. In the most striking example, rare loss-of-function mutations in the IL-10 receptor genes cause severe, very-early-onset inflammatory bowel disease in infants — a vivid demonstration of how central this single pathway is. These are associations studied in research settings, not diagnoses a test delivers.
The IL10 gene and its promoter variants
How much IL-10 you make is partly written into your DNA. The IL10 gene carries several well-studied single-nucleotide polymorphisms in its promoter region — the stretch that controls how strongly the gene is switched on. The most examined is rs1800896, the -1082 G/A variant: the G allele is generally associated with higher IL-10 production, while the A allele is linked to lower output. Two neighboring variants, rs1800871 (-819) and rs1800872 (-592), are often inherited together with rs1800896 as a haplotype that further tunes expression. Population studies have connected the lower-producing haplotypes to differences in susceptibility and severity across inflammatory and infectious conditions, though effects vary by ancestry and context.
Why genetics is only part of the picture
Your IL10 genotype sets a baseline, but it does not act alone. Diet, sleep, stress, the gut microbiome, and existing inflammatory load all shape how much IL-10 your body actually produces day to day. That is why two people with the same variant can have different circulating levels. Genetics tells you about tendencies in the pathway; it does not lock in an outcome.
How pathway-level genetic insight helps
Understanding your inflammatory pathway biology can turn vague symptoms into a more focused conversation with a provider. The Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights, including variants across inflammation-related pathways. It does not measure your IL-10 blood level, diagnose any condition, or predict disease — a blood biomarker panel and a clinician do that work. What it offers is genetic context: a map of your predispositions that complements, rather than replaces, clinical testing. PlexusDx tells you about your biology; it does not tell you what to put in your body.
What to do with the information
If you have symptoms of chronic inflammation or an autoimmune condition, work with a healthcare provider who can order the right blood tests and interpret them in context. Lifestyle levers that research links to healthier inflammatory balance — regular movement, quality sleep, and a fiber-rich diet — are broadly beneficial. Genetics is a guide, not a guarantee.
Frequently Asked Questions
What does low IL-10 mean for my health?
Low IL-10 activity means the body has less of its main anti-inflammatory brake, so inflammation may resolve more slowly. Research links reduced IL-10 signaling to inflammatory bowel disease, rheumatoid arthritis, and cardiovascular inflammation. It is a risk-associated pattern, not a diagnosis — interpretation belongs with a qualified healthcare provider.
Which gene controls IL-10 levels?
The IL10 gene, and especially its promoter variant rs1800896 (the -1082 G/A polymorphism), influences how much IL-10 you produce. The G allele is associated with higher output and the A allele with lower. Neighboring variants rs1800871 and rs1800872 fine-tune expression as part of a shared haplotype.
Can genetic testing measure my IL-10 level?
No. Genetic testing reads DNA variants that influence the IL-10 pathway, not the actual amount of IL-10 in your blood. Measuring circulating cytokines requires a blood test ordered by a clinician. Genetic insight provides pathway-level context that complements, but never replaces, laboratory biomarker measurement.
Curious how your genes shape inflammation and other pathways? Explore the Precision Peptide Genetic Test for a pathway-level view of your biology — insight you can bring to your provider alongside standard blood work.
The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways. It does not recommend, prescribe, or determine which peptides you should use. Consult a qualified healthcare provider before beginning any peptide protocol.
This article is part of the PlexusDx Education Hub. Browse all Blood Testing & Biomarkers education
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
What are the symptoms and genetic risk factors for Hemochromatosis?
Chloride Genetic Predispositions and Your Health Explained